FDA Approves Nexium

FDA Approves Nexium for Erosive Esophagitis, Gastroesophageal Reflux Disease and Prevention of Duodenal Ulcers

Nexium (esomeprazole magnesium) is a proton pump inhibitor indicated for the healing and maintenance of healing of erosive esophagitis, treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD) and for use in combination with amoxicillin and clarithromycin for H. pylori eradication to reduce the risk of duodenal ulcer recurrence.

Posted: February 2001

Related Articles:

View comments

Hide
(web1)